Clinical Trials Logo

Heart Disease clinical trials

View clinical trials related to Heart Disease.

Filter by:

NCT ID: NCT02695134 Recruiting - Heart Disease Clinical Trials

Healing Touch Prior to Cardiac Rehab

Start date: February 2016
Phase: N/A
Study type: Interventional

The purpose of the investigators proposed randomized, controlled study is to examine the effect of 6 one hour treatments of Healing Touch (HT) over 3 weeks on post-cardiac event patients, while they wait to enter a Cardiac Rehab (CR) program.Patients enrolled in the Scripps Center for Integrative Medicine (SCIM) Cardiac Rehab Program typically experience a waiting period of 3 weeks, or sometimes more, before starting the program. Secondary aims of the proposed study are to evaluate the effect of HT on CR program outcome measures of METs, BMI, physical and mental well-being, and attendance in this population. New participants in the CR program who qualify and agree to participate in the study will be consented and randomly assigned to the Intervention Group who will receive Healing Touch therapy, or to the Control Group, which will not receive HT. At baseline both groups will complete the Dartmouth Quality of Life and SF-36 Health Surveys. The questionnaires will be repeated at the end of the 3 week study period and at the end of the 3 months SCIM CR program. An effect size of 15% was chosen, with an alpha level of 0.05, 80% power, 95% confidence level, and using a two-tailed test, it was determined that a sample size of 56 patients in each group would be needed for between group comparisons. To account for potential attrition the study will enroll 124 subjects, 62 in each group. Our rationale is that Healing Touch, in addition to standard medical care will reduce post-cardiac event stress and anxiety symptoms in patients waiting to enter a cardiac rehab program, as measured by the Dartmouth Quality of Life Index and the SF36 questionnaire. Further, the investigators suggest that Healing Touch treatments will improve patient's final outcomes of the 12 week CR program.

NCT ID: NCT02694094 Enrolling by invitation - Epilepsy Clinical Trials

Impact of Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy

Start date: March 2016
Phase:
Study type: Observational

This research is being done to evaluate the short term and long term effects of ketogenic diets on measures of cardiovascular health. Such measures include cholesterol levels, blood pressure, weight, and thickening of the blood vessel wall over time. Adults aged 18 or older who are already on a ketogenic diet for at least 12 months or who are interested in beginning on the modified Atkins diet may join.

NCT ID: NCT02687763 Completed - HEART DISEASE Clinical Trials

Safety and Efficacy of ProQuad® in Children 6-24 Month Being Evaluated for Solid Organ Transplant

ProQuad®
Start date: December 2015
Phase: Early Phase 1
Study type: Interventional

A prospective, multisite study to evaluate the Impact of Measles, Mumps, Rubella and Varicella ProQuad® vaccination in pediatric patients 6-24 months of age who are being considered and/or evaluated for any solid organ transplant (heart, liver or kidney)

NCT ID: NCT02684331 Completed - Clinical trials for Diabetes Mellitus, Type 2

CMR in Type 2 Diabetes Mellitus Patients

Start date: January 2016
Phase:
Study type: Observational

The study will be performed as a cross-sectional survey. 300 Type 2 diabetes patients (T2DM), with or without known cardiovascular disease, will be recruited from the diabetes outpatient clinic, Slagelse Hospital. The patients will undergo echocardiography, Cardiac magnetic resonance imaging (CMR), clinical examination and will be asked to fill out questionnaires. This study project sets out to answer the following hypotheses: 1. Patients with T2DM have an increased risk of developing diastolic dysfunction. Using CMR, the investigators wish to measure left ventricle peak filling rate and passive atrial emptying fraction as a measure of cardiac diastolic function. The investigators hypothesize that classic T2DM markers such as levels of urinary albumin excretion, retinopathy, autonomic neuropathy, hypertension, dyslipidemia, elevated HgbA1c, T2DM duration, etc. are associated with pathological findings by CMR. 2. Patients with T2DM have impaired left ventricle myocardial perfusion as determined by gadolinium contrast CMR. The investigators hypothesize that the classic markers and risk factors mentioned above, are associated with left ventricle myocardial hypoperfusion as determined by gadolinium contrast CMR.

NCT ID: NCT02674204 Terminated - Breast Cancer Clinical Trials

STOP Heart Disease in Breast Cancer Survivors Trial

STOP
Start date: May 5, 2016
Phase: Phase 2
Study type: Interventional

The purpose of this study is to to examine the effects of atorvastatin, a type of statin, on changes to the heart among women undergoing breast cancer treatment. Atorvastatin may reduce or eliminate the harmful effects of chemotherapy treatment to the heart tissue of breast cancer patients.

NCT ID: NCT02527044 Active, not recruiting - Heart Disease Clinical Trials

Impact of Preoperative FFR on Arterial Bypass Graft Functionality

IMPAG
Start date: November 2015
Phase: N/A
Study type: Interventional

This study was designed to evaluate the correlation between pre-operative FFR and the functionality of arterial bypass grafts six months after coronary artery bypass grafting. Patients with multi-vessel coronary artery disease will undergo both a coronary angiogram and FFR during their diagnostic workup. All patients will be referred for surgical revascularization (CABG) with planned use of arterial grafts. Six months after surgery, patients will undergo an angiogram to assess the functionality of the bypass graft and anastomosis.

NCT ID: NCT02523144 Completed - Heart Disease Clinical Trials

Dexmedetomidine in Children Having Transthoracic Echocardiography

Start date: September 2014
Phase: Phase 4
Study type: Interventional

Sedation Techniques for children undergoing transthoracic echocardiography (TTE).

NCT ID: NCT02515539 Recruiting - Clinical trials for Cardiovascular Disease

Early Feasibility Study of the CardiAQ™ TMVI System (Transfemoral and Transapical DS)

Start date: August 2015
Phase: N/A
Study type: Interventional

The purpose of the study is to generate early US feasibility data of the CardiAQ™ Transcatheter Mitral Valve Implant System. The study will enroll patients with moderate to severe mitral valve regurgitation who are considered high risk for mortality and morbidity from conventional open-heart surgery.

NCT ID: NCT02504762 Completed - Diabetes Clinical Trials

HYbrid CoronAry Revascularization in DiabeticS

HYCARDS
Start date: August 2015
Phase: N/A
Study type: Interventional

To evaluate whether an HCR strategy is more or less effective than conventional coronary artery bypass grafting (cCABG), in diabetic patients with multivessel CAD involving the left anterior descending artery (LAD), who do not present in the context of acute ST-elevation myocardial infarction (STEMI).

NCT ID: NCT02499731 Completed - Obesity Clinical Trials

Strong Hearts: Rural CVD Prevention

Start date: March 2014
Phase: N/A
Study type: Interventional

Strong Hearts, Healthy Communities is a research study which aims to reduce cardiovascular disease (CVD), improve quality of life, and reduce CVD related health care costs in rural communities. The investigators' aim is to better understand how changes in lifestyle can affect the health of rural women and others in their communities.